Biography

Dr Atallah is the Associate Dean for Clinical Affairs at Dubai Medical University. Prior to joining DMU he served as Cardiovascular Senior Pharmacotherapy Specialist at Cleveland Clinic Abu Dhabi and Clinical Associate Professor at Cleveland Clinic Lerner College of Medicine. Prior to joining Cleveland Clinic he was on faculty as Assistant Professor of Clinical Pharmacy at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh. Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post graduate residency at Winchester Medical Center in Virginia. He was awarded the “Graduate of the Last Decade” award by his alma mater. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from ASHP. Dr Atallah is a fellow of the Heart Failure Society of America (HFSA) and the American College of Clinical Pharmacy (ACCP). He has several publications and presentations at national and international conferences. He was awarded the 2021 ACCP Cardiology PRN international award. His research interests are in various aspects of cardiovascular pharmacotherapy with focus on antithrombotic therapy, heart failure and hyperlipidemia.

Back

Education

• Bachelor of Science in Biology, American University of Beirut, Lebanon (2003-2006)
• Master of Science in Biology, Fairleigh Dickinson University, New Jersey, USA (2006-2008)
• Doctor of Pharmacy, Shenandoah University, Bernard J Dunn School of Pharmacy, Virginia, USA (2008-2012)
• ASHP-Accredited PGY-1 Pharmacy Practice Residency, Winchester Medical Center, Virginia, USA (2012-2013)
• Teaching Certificate, Shenandoah University, Virginia, USA (2012-2013)
• Advanced Antithrombotic Traineeship, ASHP Foundation, USA (2016-2017)

Back

Research Interests

• Cardiovascular pharmacotherapy
• Pharmacist-led initiatives
• Clinical outcomes

Back

Research Publications

• El Khatib, O., Hisham, M., Al Shaqfa, S., Ghazal, I., & Atallah, B. (2025). Anticoagulation in the setting of concomitant temporary mechanical circulatory support: Experience from a quaternary care center in the Middle East and review of the literature. International Journal of Artificial Organs, 48(9), 686–697.
• Fiuzat, M., Atallah, B., Page, R. L., & Vardeny, O. (2025). The current landscape of training, practice, and roles of pharmacists in the field of heart failure. JACC: Heart Failure, 13(8), 102551.
• Alaryani, J., Manla, Y., Abidi, E., Bader, F. M., & Atallah, B. (2025). Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist-led protocol. JACCP Journal of the American College of Clinical Pharmacy, 8(3), 182–191.
• Elshorbagy, A. K., Lyons, A. R. M., Vallejo-Vaz, A. J., Le, H., & Ray, K. K. (2024). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: A worldwide cross-sectional study. The Lancet Diabetes & Endocrinology, 12(11), 811–823.
• El Nekidy, W. S., Abidi, E., Nabil, S., Mallat, J., & Akour, A. A. (2024). The safety and effectiveness of apixaban in patients with end-stage kidney disease on dialysis: A retrospective observational study. Journal of Clinical Medicine, 13(5), 1351.
• Khattab, M. H., Baguneid, M. S., Ali, B. R., Rahma, A. T., & Aburuz, S. M. (2023). A review of pharmacogenomics studies assessing the knowledge and attitudes of physicians and pharmacists across the Arab and Middle Eastern Region. Pharmacy Practice, 21(3), 2828.
• Hisham, M., Ghalib, H. H., Kakar, V., Bader, F. M., & Atallah, B. (2023). Anticoagulation practices and complications associated with Impella® support at an advanced cardiac center in the Middle East gulf region. Journal of Thrombosis and Thrombolysis, 56(1), 164–174.
• Hashmani, S., Madhyastha, R., El Nekidy, W. S., Bader, F. M., & Attallah, N. M. (2023). Polypharmacy in cardiorenal syndrome patients. Clinical Nephrology, 99(3), 141–148.
• El-Lababidi, R. M., Atallah, B., & Abdel-Razig, S. (2023). Design and implementation of an antimicrobial stewardship certificate program in the United Arab Emirates. International Medical Education, 2(1), 41–48.
• Anouassi, Z., Abril, C. M., Ismail, G., Bafadel, A., & Atallah, B. (2023). A case of hemorrhagic cholecystitis in a patient on apixaban after COVID-19 infection. American Journal of Case Reports, 24, e939677.
• Nadarajah, R., Ludman, P. F., Appelman, Y. E. A., Alyavi, A. L., & Uzokov, J. K. (2023). Cohort profile: The ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry. European Heart Journal – Quality of Care and Clinical Outcomes, 9(1), 8–15.
• El Nekidy, W. S., AlMuti, K., ElRefaei, H., Hamed, F., & Mallat, J. (2022). QT prolongation in critically ill patients with SARS-CoV-2 infection. Journal of Cardiovascular Pharmacology and Therapeutics, 27.
• Vallejo-Vaz, A. J., Stevens, C. A. T., Lyons, A. R. M., Le, T. T., & Le, H. (2021). Global perspective of familial hypercholesterolaemia: A cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). The Lancet, 398(10312), 1713–1725.
• AlHabib, K. F., Al-Rasadi, K. H., Almigbal, T. H., Amin, H. E., & Altaradi, H. B. (2021). Familial hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH registry. PLoS ONE, 16(6), e0251560.
• Al Bitar, M., Shantouf, R. S., Alazzoni, A., Almahmeed, W. A., & Atallah, B. (2025). Ischemia with no obstructed coronary arteries and microvascular testing procedures: A review of utility, pharmacotherapy, and current challenges. Frontiers in Cardiovascular Medicine, 12, 1523352.
• Abidi, E., El Nekidy, W. S., Atallah, B., Kakar, V., & Mallat, J. (2023). Sustaining life versus altering life-saving drugs: Insights to explain the paradoxical effect of extracorporeal membrane oxygenation on drugs. Journal of Clinical Medicine, 12(11), 3748.
• AlSalama, F., Alzaabi, S., Salloum, C., Ghalib, H. H., & Atallah, B. (2023). Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: A case report and review of the literature. Drugs & Therapy Perspectives, 39(4), 147–155.
• Mallah, S. I. Y., Ghorab, O. K. H. A., Al-Salmi, S., El-Lababidi, R. M., & AlQahtani, M. M. (2021). COVID-19: Breaking down a global health crisis. Annals of Clinical Microbiology and Antimicrobials, 20(1), 35.
• Khan, U. A., Atallah, B., & Alinier, G. (2025). Advancing extracorporeal life support in the South-West Asian and African continent. ASAIO Journal, 71(Suppl 1), 1.
• Atallah, B., & Ghalib, H. H. (2024). Pooling the NT-proBNP benefits of ARNI: Fret the index hospitalization no more. Journal of the American College of Cardiology, 83(12), 1133–1135.

  Back